Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Molecular Methods in Clinical Microbiology

Molecular Virology in the Clinical Laboratory

Deborah Josko
American Society for Clinical Laboratory Science October 2010, 23 (4) 231-236; DOI: https://doi.org/10.29074/ascls.23.4.231
Deborah Josko
University of Medicine and Dentistry of New Jersey, Scotch Plains, NJ
CM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: joskotda@umdnj.edu
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Deborah Josko, PhD, M(ASCP)CM, MLT,SM⇑
    1. University of Medicine and Dentistry of New Jersey, Scotch Plains, NJ
  1. Address for correspondence: Deborah Josko, PhD, M(ASCP)CM, MLT,SM, associate professor, Department of Clinical Laboratory Sciences, Medical Laboratory Science Program, University of Medicine and Dentistry of New Jersey, 1776 Raritan Road, Scotch Plains, NJ 07076. (908) 889-2422. joskotda{at}umdnj.edu.
  1. Compare and contrast traditional PCR and real-time PCR methodologies.

  2. Describe common real-time PCR fluorescent detection chemistries.

  3. Discuss various real-time PCR HIV-1 assays.

  4. Explain the principle of transcription mediated assays and hybridization protection assays.

  5. Discuss the methodology of the Hybrid Capture 2 High-Risk HPV test.

  6. List FDA cleared molecular diagnostic viral assays.

Extract

The “gold standard” for viral identification is the conventional cell culture. Although cell culture has proven effective in the identification process of viral pathogens, there are shortcomings to this technology. Turn around times can range anywhere from days to weeks depending on the virus isolated; contamination rates are high; and some viruses are non-culturable making it virtually impossible to identify the microorganism. The need for rapid, sensitive, and accurate identification is imperative to ensure appropriate treatment and improve patient care. Although there are many rapid methods and serological assays available to identify viral agents, nucleic acid based detection and amplification-based assays are proving to be the most accurate and quickest identification processes. Results are reported in two to three hours compared to days or weeks for conventional cell culture.

The invention of the polymerase chain reaction (PCR) by Dr. Kary Mullis in 1983 revolutionized the field of molecular biology and modern medicine. Cetus Corporation, the company Dr. Mullis was working for at the time of his discovery, was awarded the patent for PCR in 1987.1 Cetus in turn sold the rights to Hoffman La-Roche in 1992 and in 1993, the FDA approved the first diagnostic PCR assay; the AMPLICOR Chlamydia trachomatis test, in the U.S.1 Since then, the use of PCR technology in the clinical laboratories has escalated, especially in the last two decades. Traditional PCR, however, proved to have several shortcomings. Some of the limitations include detection at the end point of the reaction, which results in low sensitivity…

ABBREVIATIONS: bDNA = Branched DNA; CD = Cluster of Differentiation; CI = Confidence Interval; CIN = Cervical Intraepithelial Neoplasia; DNA = Deoxyribonucleic Acid; FDA = Food and Drug Administration; FRET = Fluorescence Resonance Energy Transfer; HBV = Hepatitis B Virus; HCV = Hepatitis C Virus; HIV = Human Immunodeficiency Virus; HPA = Hybridization Protection Assay; NASBA = Nucleic Acid Sequence Based Amplification; PCR = Polymerase Chain Reaction; QS = Quantitation Standard; RLU/CO = Relative Light Units/Cutoff Value; RNA = Ribonucleic Acid; RT = Reverse Transcription; RT-PCR = Reverse Transcription Polymerase Chain Reaction; Taq = Thermus aquaticus; TMA = Transcription-Mediated Amplification.

    INDEX TERMS
  • Molecular Methods
  • Polymerase Chain Reaction
  • Real-Time PCR
  • TaqMan Probes
  • Molecular Beacons
  • Dual Hybridization Probes
  • Fluorescence Resonance Energy Transfer
  • Transcription-Medicated Amplification
  • Hybridization Protection Assay
  • Hybrid Capture
  • FDA Cleared Molecular Viral Assays
  1. Compare and contrast traditional PCR and real-time PCR methodologies.

  2. Describe common real-time PCR fluorescent detection chemistries.

  3. Discuss various real-time PCR HIV-1 assays.

  4. Explain the principle of transcription mediated assays and hybridization protection assays.

  5. Discuss the methodology of the Hybrid Capture 2 High-Risk HPV test.

  6. List FDA cleared molecular diagnostic viral assays.

  • © Copyright 2010 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 23 (4)
American Society for Clinical Laboratory Science
Vol. 23, Issue 4
Fall 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Virology in the Clinical Laboratory
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Molecular Virology in the Clinical Laboratory
Deborah Josko
American Society for Clinical Laboratory Science Oct 2010, 23 (4) 231-236; DOI: 10.29074/ascls.23.4.231

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Molecular Virology in the Clinical Laboratory
Deborah Josko
American Society for Clinical Laboratory Science Oct 2010, 23 (4) 231-236; DOI: 10.29074/ascls.23.4.231
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • Evaluation Of SYBR Green Real Time PCR For Detecting SARS-CoV-2 From Clinical Samples
  • Automation and Molecular Diagnostics: a New Era in Clinical Microbiology
  • Evolution of the Clinical Microbiology Laboratory
  • Google Scholar

More in this TOC Section

  • Molecular Methods in Clinical Microbiology Introduction
  • Molecular Diagnostics in the Public Health Laboratories
  • Molecular Bacteriology in the Clinical Laboratory
Show more Focus: Molecular Methods in Clinical Microbiology

Similar Articles

Keywords

  • Molecular Methods
  • polymerase chain reaction
  • Real-Time PCR
  • TaqMan Probes
  • Molecular Beacons
  • Dual Hybridization Probes
  • Fluorescence Resonance Energy Transfer
  • Transcription-Medicated Amplification
  • Hybridization Protection Assay
  • Hybrid Capture
  • FDA Cleared Molecular Viral Assays

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire